FBL20 Antibodies

Santa Cruz Biotechnology offers a broad range of FBL20 monoclonal antibodies for research focused on understanding FBL20 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FBL20, also known as Fibrillarin, is a nucleolar protein that plays a critical role in the biogenesis of ribosomes and the processing of pre-rRNA. The nucleolar structure assembly depends on FBL20, which facilitates rRNA modification essential for protein synthesis in cells. Research has shown that FBL20 influences various cellular processes and may have implications in multiple disease states. Understanding FBL20's molecular mechanisms can provide valuable insights into cellular function and potential therapeutic approaches. Investigating FBL20's role in ribosome biogenesis can reveal new perspectives on protein synthesis regulation. Current research indicates that FBL20 may serve as a promising target for therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of FBL20's role in health and disease.